Duc Ha MD, MAS

Clinician Investigator

Duc HaDuc Ha MD, MAS, is an early-stage Clinician Investigator at the Kaiser Permanente Colorado Institute for Health Research. His research interests include physical activity and exercise, lung cancer survivorship, and lung cancer outcomes. He is particularly interested in the role of physical activity and exercise in improving the health status of lung cancer survivors following curative-intent therapy.

Dr. Ha received his medical training at the University of Colorado Denver School of Medicine, completed residency in Internal Medicine at the Cleveland Clinic, and Pulmonary/Critical Medicine and Postdoctoral Research fellowships at the University of California San Diego. While in fellowship, he also obtained a Master of Advanced Study (MAS) degree in clinical research.

Dr. Ha is a long-standing member of the American Thoracic Society and more recently, the American Society of Clinical Oncology.


Selected Research

Current

  • The Lung PROSPR Research Center (Lung-PRC)
    Funder: National Cancer Institute
    Study End Date: 3/31/2023

Complete

  • Assessment of Health in Lung Cancer Survivors
    The aims of this project are: (1) to assess patient-reported outcome measures in lung cancer survivors including for: generic and cancer-specific quality of life (QoL) and general cancer- and lung cancer-specific symptoms (e.g. fatigue, dyspnea, anxiety, depression, and sleep disturbances); (2) assess functional capacity in lung cancer survivors using the six-minute walk test; and (3) analyze the relationship between function capacity and QoL.
    Funder: National Cancer Institute
    Study End Date: 6/30/2018

  • Physiological and Patient-reported Outcome Assessments in Lung Cancer
    The aims of this project are: (1) in a cross-sectional study of lung cancer survivors eligible for long-term cure, assess and analyze the relationship between exercise physiological measures of health and patient-reported outcomes; and (2) in a prospective observational cohort study, quantify the health decrements associated with curative-intent lung cancer treatment using exercise physiological and patient-reported outcome measures.
    Funder: American Cancer Society
    Study End Date: 8/30/2018